18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3530 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />

MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

(51) (97) (54)<br />

C07D 498/04 (2006.01) EP 2<strong>09</strong>4713 * EPOTHILONE ANALOGUES MODIFIED AT POSITIONS C12-C13 AS ANTICANCER DRUGS<br />

C07D 498/08 (2006.01) EP 2086982 * HCV NS3 PROTEASE INHIBITORS<br />

C07D 498/18 (2006.01) EP 2086982 * HCV NS3 PROTEASE INHIBITORS<br />

C07D 513/04 (2006.01) EP 2<strong>09</strong>4671 * HETEROBICYCLIC METALLOPROTEASE INHIBITORS<br />

C07D 513/04 (2006.01) EP 2<strong>09</strong>4690 * 2-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS<br />

C07F 5/02 (2006.01) EP 2<strong>09</strong>8529 * PH-SENSITIVE FLUORESCENT PROBE<br />

C07F 5/02 (2006.01) EP 2<strong>09</strong>9790 * PROCESS FOR PREPARING NEBIVOLOL<br />

C07F 7/02 (2006.01) EP 2074135 * SILICON DERIVATIVES FOR PET IMAGING<br />

C07F 9/<strong>09</strong> (2006.01) EP 2<strong>09</strong>9768 * AGONISTS OF THE SPHINGOSINE-1-PHOSPHATE RECEPTOR<br />

C07F 9/30 (2006.01) EP 2<strong>09</strong>4720 * SELECTIVE INHIBITORS OF NEUROTENSIN DEGRADING ENZYMES<br />

C07H 15/12 (2006.01) EP 2<strong>09</strong>6116 * SODIUM SALT OF DISACCHARIDE COMPOUND, METHOD FOR PRODUCING THE SAME,<br />

AND USE OF THE SAME<br />

C07H 21/00 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />

OBTAINING AND USING SAME<br />

C07H 21/02 (2006.01) EP 2089412 * SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS<br />

C07H 21/02 (2006.01) EP 2<strong>09</strong>7435 * THERAPEUTIC TREATMENTS BASED ON ADMINISTRATION OF SMALL RNA FRAGMENTS<br />

C07H 21/04 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />

C07H 21/04 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />

C07H 21/04 (2006.01) EP 2<strong>09</strong>7539 * POLYMORPHISMS IN THE UROCORTIN 3 GENE AND THEIR ASSOCIATIONS WITH<br />

MARBLING AND SUBCUTANEOUS FAT DEPTH IN BEEF CATTLE<br />

C07J 53/00 (2006.01) EP 2019114 Process for the preparation of Drospirenone<br />

C07K 1/00 (2006.01) EP 2089428 * CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES<br />

C07K 1/13 (2006.01) EP 2074135 * SILICON DERIVATIVES FOR PET IMAGING<br />

C07K 14/07 (2006.01) EP 2<strong>09</strong>7517 * MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC<br />

METHODS<br />

C07K 14/245 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C07K 14/25 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C07K 14/315 (2006.01) EP 2<strong>09</strong>7100 * PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS<br />

AND USES RELATING THERETO<br />

C07K 14/435 (2006.01) EP 1985304 Novel compounds and their effects on feeding behaviour<br />

C07K 14/47 (2006.01) EP 2<strong>09</strong>2069 * MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL<br />

ACTIVITY<br />

C07K 14/475 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C07K 14/52 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C07K 14/535 (2006.01) EP 2<strong>09</strong>9495 * CONJUGATES OF A G-CSF MOIETY AND A POLYMER<br />

C07K 14/705 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />

C07K 14/705 (2006.01) EP 2<strong>09</strong>4732 * DR6 ANTIBODIES INHIBITING THE BINDING OF DR6 TO APP, AND USES THEREOF IN<br />

TREATING NEUROLOGICAL DISORDERS<br />

C07K 14/705 (2006.01) EP 2<strong>09</strong>7444 * TRANSGENIC ANIMAL WITH ENHANCED IMMUNE RESPONSE AND METHOD FOR THE<br />

PREPARATION THEREOF<br />

C07K 14/71 (2006.01) EP 2<strong>09</strong>2069 * MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL<br />

ACTIVITY<br />

C07K 14/71 (2006.01) EP 2<strong>09</strong>9920 * TRANSGENIC MICE EXPRESSING HUMANIZED VEGF<br />

C07K 14/82 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />

COMPRISING THE SAME<br />

C07K 16/00 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />

C07K 16/00 (2006.01) EP 2088997 * LIQUID ANTI-RABIES ANTIBODY FORMULATIONS<br />

C07K 16/00 (2006.01) EP 2089428 * CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES<br />

C07K 16/00 (2006.01) EP 2<strong>09</strong>4282 * ANTI-TSG101 ANTIBODIES AND THEIR USES FOR TREATMENT OF VIRAL INFECTIONS<br />

C07K 16/00 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />

C07K 16/00 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />

CONTAINING MODIFIED TOXINS AND USES THEREOF<br />

C07K 16/00 (2006.01) EP 2<strong>09</strong>7747 * ANALYTICAL METHOD FOR ANALYZING C-TERMINUS TRUNCATION<br />

C07K 16/00 (2006.01) EP 2<strong>09</strong>9824 * ENTEROCOCCUS FAECALIS AND/OR ENTEROCOCCUS FAECIUM ANTIGEN<br />

C07K 16/08 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />

OBTAINING AND USING SAME<br />

C07K 16/18 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />

C07K 16/18 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

C07K 16/18 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />

C07K 16/18 (2006.01) EP 2<strong>09</strong>4729 * ABETA ANTIBODY PARENTERAL FORMULATION<br />

C07K 16/18 (2006.01) EP 2<strong>09</strong>6122 * ANTI-HUMAN DLK-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!